An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01970111 |
Recruitment Status :
Completed
First Posted : October 25, 2013
Last Update Posted : April 18, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinocerebellar Degeneration | Drug: KPS-0373, High dose Drug: KPS-0373, Low dose | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Actual Primary Completion Date : | July 2015 |

Arm | Intervention/treatment |
---|---|
Experimental: KPS-0373 |
Drug: KPS-0373, High dose Drug: KPS-0373, Low dose |
- SARA (Scale for the Assessment and Rating of Ataxia) [ Time Frame: 52 weeks ]
- SF-8 (QOL) [ Time Frame: 52 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Inclusion Criteria:
- Japanese SCD patients with mild to moderate ataxia (Completion of the KPS1301 study)
Exclusion Criteria:
- Less than 75% of compliance in KPS1301 study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01970111
Japan | |
Tokyo and Other Japanese Cities, Japan |
Responsible Party: | Kissei Pharmaceutical Co., Ltd. |
ClinicalTrials.gov Identifier: | NCT01970111 |
Other Study ID Numbers: |
KPS1302 |
First Posted: | October 25, 2013 Key Record Dates |
Last Update Posted: | April 18, 2016 |
Last Verified: | April 2016 |
Spinocerebellar degeneration (SCD) Thyrotropin-Releasing Hormone (TRH) Spinocerebellar Ataxia (SCA) Cortical Cerebellar Atrophy (CCA) |
Spinocerebellar Degenerations Spinocerebellar Ataxias Cerebellar Diseases Brain Diseases Central Nervous System Diseases Nervous System Diseases Spinal Cord Diseases |
Heredodegenerative Disorders, Nervous System Neurodegenerative Diseases Genetic Diseases, Inborn Cerebellar Ataxia Ataxia Dyskinesias Neurologic Manifestations |